There are heightened concerns about informed consent forms service members and veterans may have signed up to participate in clinical trials using remdesivir to treat COVID-19.
“Are you a service member or veteran participating in the US Army Medical Research and Development Command (USAMRDC) clinical trial NCT04302766 for the treatment of COVID-19 with remdesivir (GS-5734â„¢)? Are you a spouse or family member of a service member or veteran participating in the trial try? Do you have an Informed Consent Form?”
Service members and veterans, or their family members, are encouraged to reach out if they are affected by using remdesivir for the treatment of COVID-19 between 2020 and 2021. Click here to tell your story.
First published by Gateway Pundit on October 4, 2024, The Remdesivir Papers revealed evidence that 64 percent of service members and veterans who died of COVID-19 were also given remdesivir.
The authors of the report continue to be troubled by the Informed Consent Form provided to service members and veterans at the start of the US Army Medical Research and Development Command (USAMRDC) clinical trial NCT04302766. Gateway spoke to attorney R. Davis Younts to address some of these concerns.
A retired Air Force lieutenant colonel and former judge advocate general (JAG) said the form was “in the most basic sense” a contract. “I would always argue that from a legal point of view, all the same principles (contracts) would apply,” he said.
“According to the principles of contract law,” Younts said, “it’s basically an agreement between two people who come together about something.” For him, honesty is the main issue for the “benefit of the offer”. In layman’s terms, both sides of the agreement are guaranteed to receive what they want without cheating.
Speaking more specifically about the form provided by the USAMRDC, Younts offered his thoughts on the following statement found in Section 6.1 of the form:
“Remdesivir has also been given to Ebola survivors in West Africa and people with Ebola virus disease. Some of these people have side effects.
Considering that The New England Journal of Medicine (NEJM) reported, in May 2019, that the use of remdesivir caused the highest death rate among participants in a trial of four investigational therapies for Ebola in the Democratic Republic of Congo, Younts said, “this informed consent is very misleading Ninety-three of the 175 (53.1 percent) patients who died were in the group taking remdesivir.
According to Younts, “the whole point of informed consent — with all the laws and litigation — is that you should have the freedom and the opportunity to make decisions about your health care.” He added that “you can’t really give consent if you’re not given accurate information.”
For him, considering the number of deaths reported by NEJM in 2019, the statement that “some people have side effects” is “very disturbing, (because) there is a lot of fraud out there.”
In addition, Section 7 of the USAMRDC Informed Consent Form for clinical trial NCT04302766 also offers “at best, the website will include a summary of the results.” On the contrary, no results are posted to the site. “They didn’t honor the contract,” Younts said. “For any medical provider, pharmaceutical company, physician, military treatment facility, or anyone else to say they will provide results and then not provide them is a clear failure to meet the terms of the contract.”
Many email inquiries about these concerns were sent to participating military treatment facilities. A FOIA request was also filed with the US Army Medical Research and Development Command (USAMRDC) on September 24. The request is assigned a case number with an estimated completion date of January 10, 2024.
In addition, on September 27, the congressional investigation of Rep. Clay Higgins (R-Louisiana) sent to Secretary of Defense Lloyd Austin, copying the Secretary of the US Health and Human Services, the Commissioner of the US Food and Drug Administration, the Commanding General of the USAMRDC. Gen. Paula C. Lodi and others.
